• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

部分氟化抗孕激素和中孕激素的合成与生物评价。

Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins.

机构信息

Evestra, Inc., San Antonio, TX, USA.

出版信息

Steroids. 2013 Feb;78(2):255-67. doi: 10.1016/j.steroids.2012.09.010. Epub 2012 Nov 21.

DOI:10.1016/j.steroids.2012.09.010
PMID:23178161
Abstract

A series of antiprogestins have been synthesized by partially fluorinating the steroid molecule in positions relevant for receptor binding. By introducing fluorine at the exo-methylene of the 17 spirofuran ring, we obtained partial agonists (mesoprogestins) with significant applications for antiproliferative and antiovulatory treatment strategies in gynecological therapy such as uterine fibroids, endometriosis and heavy menstrual bleeding. Compared to the standard drug RU486, our synthesized compounds exhibited considerable dissociation between antiprogestational and antiglucocorticoid PR receptors. Furthermore, our studies have shown that pure antiprogestins can be generated by partially fluorinating the 17 propenyl and propynl group or by substituting the 4' acetyl phenyl group in the 11 position using trifluromethyl group.

摘要

已经通过在与受体结合相关的位置部分氟化甾体分子来合成一系列抗孕激素。通过在 17 螺环呋喃环的亚甲烯基处引入氟原子,我们得到了具有显著应用前景的部分激动剂(中孕激素),可用于妇科治疗中的抗增殖和抗排卵治疗策略,例如子宫肌瘤、子宫内膜异位症和月经过多。与标准药物 RU486 相比,我们合成的化合物在抗孕激素和抗糖皮质激素 PR 受体之间表现出相当大的分离。此外,我们的研究表明,通过部分氟化 17 丙烯基和丙炔基基团,或通过用三氟甲基取代 11 位的 4'乙酰苯基基团,可以生成纯的抗孕激素。

相似文献

1
Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins.部分氟化抗孕激素和中孕激素的合成与生物评价。
Steroids. 2013 Feb;78(2):255-67. doi: 10.1016/j.steroids.2012.09.010. Epub 2012 Nov 21.
2
Synthesis and biological evaluation of 11' imidazolyl antiprogestins and mesoprogestins.11' 咪唑基抗孕激素和中效孕激素的合成及生物学评价
Steroids. 2014 Dec;92:45-55. doi: 10.1016/j.steroids.2014.08.017. Epub 2014 Aug 28.
3
In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.CDB - 2914、CDB - 4124和米非司酮的假定代谢物及合成衍生物的体外抗孕激素/抗糖皮质激素活性以及孕激素和糖皮质激素受体结合情况。
J Steroid Biochem Mol Biol. 2004 Mar;88(3):277-88. doi: 10.1016/j.jsbmb.2003.12.004.
4
CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914.CDB - 4124及其推定的单去甲基代谢物CDB - 4453是具有降低的抗糖皮质激素活性的强效抗孕激素:与米非司酮和CDB - 2914的体外比较
Mol Cell Endocrinol. 2002 Feb 25;188(1-2):111-23. doi: 10.1016/s0303-7207(01)00743-2.
5
Antiprogestins: mechanism of action and contraceptive potential.抗孕激素:作用机制与避孕潜力
Annu Rev Pharmacol Toxicol. 1996;36:47-81. doi: 10.1146/annurev.pa.36.040196.000403.
6
History and perspectives of antiprogestins from the chemist's point of view.
Hum Reprod. 1994 Jun;9 Suppl 1:12-31. doi: 10.1093/humrep/9.suppl_1.12.
7
Next step in the development of mesoprogestins: the preclinical profile of EC313.中孕激素研发的下一步:EC313 的临床前概况。
Front Endocrinol (Lausanne). 2023 Sep 8;14:1201547. doi: 10.3389/fendo.2023.1201547. eCollection 2023.
8
Identification and characterization of novel estrogen receptor-beta-sparing antiprogestins.新型保留雌激素受体β的抗孕激素的鉴定与表征
Endocrinology. 2002 Aug;143(8):3071-82. doi: 10.1210/endo.143.8.8942.
9
Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.一种新型高效孕酮受体拮抗剂的合成及生物活性
J Med Chem. 2000 Dec 28;43(26):5010-6. doi: 10.1021/jm001000c.
10
Syntheses and antigestagenic activity of mifepristone derivatives.米非司酮衍生物的合成及其抗孕激素活性。
J Med Chem. 2009 Mar 12;52(5):1268-74. doi: 10.1021/jm800985z.

引用本文的文献

1
Defluorination of HFCs by a magnesium reagent.用镁试剂对氢氟碳化合物进行脱氟反应。
Dalton Trans. 2024 Apr 16;53(15):6524-6528. doi: 10.1039/d4dt00636d.
2
Next step in the development of mesoprogestins: the preclinical profile of EC313.中孕激素研发的下一步:EC313 的临床前概况。
Front Endocrinol (Lausanne). 2023 Sep 8;14:1201547. doi: 10.3389/fendo.2023.1201547. eCollection 2023.
3
StackPR is a new computational approach for large-scale identification of progesterone receptor antagonists using the stacking strategy.
StackPR 是一种使用堆叠策略进行大规模鉴定孕激素受体拮抗剂的新计算方法。
Sci Rep. 2022 Sep 30;12(1):16435. doi: 10.1038/s41598-022-20143-5.
4
Repurposing of F-gases: challenges and opportunities in fluorine chemistry.F 气体的再利用:氟化学面临的挑战和机遇。
Chem Soc Rev. 2022 Jun 20;51(12):4977-4995. doi: 10.1039/d1cs01072g.
5
Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity.新型 RU486(米非司酮)类似物对委内瑞拉马脑炎病毒的活性增强,但孕激素受体拮抗活性降低。
Sci Rep. 2019 Feb 22;9(1):2634. doi: 10.1038/s41598-019-38671-y.
6
The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.甾体激素受体在乳腺导管原位癌(DCIS)中的新兴作用。
J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):237-248. doi: 10.1007/s10911-018-9416-0. Epub 2018 Oct 18.
7
Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.雌二醇与选择性孕激素受体调节剂(SPRMs)联合应用对人乳腺癌细胞的体内外作用
PLoS One. 2016 Mar 24;11(3):e0151182. doi: 10.1371/journal.pone.0151182. eCollection 2016.